A subset of patients with JPS also has hereditary hemorrhagic telangiectasia (HHT), more commonly seen in SMAD4 mutation carriers and characterized by mucocutaneous telangiectasias, gastrointestinal arteriovenous malformations and pulmonary arterio-venous malformations. This evidence concerns the gene SMAD4 and hereditary hemorrhagic telangiectasia.